Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × ferric derisomaltose × Classical hematology × Clear all

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Anemia, Iron-Deficiency 1

Interventions

avatrombopag 4 iron isomaltoside 1000 3 ferric carboxymaltose 3 Cytarabine 3 hetrombopag 2 eltrombopag 2 Rivaroxaban 2 Radiotherapy 2 Meropenem 2 Idarubicin 2 Etoposide 2 Erythropoietin 2 Cyclophosphamide 2 thymoglobulin 1 stinging nettle lectin 1 raltitrexed 1 peppermint oil 1 pegfilgrastim 1 oprelvekin 1 fludarabine phosphate 1 fludarabine 1 ferrous succinate 1 ferrous fumarate 1 ferric derisomaltose 1 epoetin beta 1 Vitamin B 12 1 Vancomycin 1 Valproic Acid 1 Trabectedin 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05467319 2022-07-20

FORGE

Alberta Health Services, Calgary

Phase 3 Unknown

Classical hematology

Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡